Cynosure Group LLC Reduces Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Cynosure Group LLC decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 54.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 893 shares of the biotechnology company’s stock after selling 1,062 shares during the quarter. Cynosure Group LLC’s holdings in Axon Enterprise were worth $531,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Public Sector Pension Investment Board raised its stake in shares of Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after buying an additional 500 shares during the period. Friedenthal Financial increased its holdings in Axon Enterprise by 961.7% in the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after acquiring an additional 1,231 shares in the last quarter. Principal Financial Group Inc. raised its stake in Axon Enterprise by 33.1% during the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after acquiring an additional 33,869 shares during the period. XTX Topco Ltd lifted its holdings in Axon Enterprise by 20.6% during the third quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock valued at $2,258,000 after purchasing an additional 964 shares in the last quarter. Finally, Artemis Investment Management LLP boosted its position in shares of Axon Enterprise by 21.4% in the fourth quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock worth $56,528,000 after purchasing an additional 16,792 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently commented on AXON shares. TD Cowen initiated coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Robert W. Baird lifted their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Finally, JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. According to MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $604.67.

Insider Buying and Selling

In other news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $558.42 on Thursday. The firm has a fifty day simple moving average of $585.99 and a two-hundred day simple moving average of $552.79. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $42.79 billion, a P/E ratio of 144.29, a PEG ratio of 5.17 and a beta of 1.13.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.